The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma (Q35053326)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma |
scientific article |
Statements
1 reference
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma (English)
1 reference
Henry S Friedman
1 reference
Darell D Bigner
1 reference
Annick Desjardins
1 reference
Allan H Friedman
1 reference
David A Reardon
1 reference
James J Vredenburgh
1 reference
James E Herndon
1 reference
Katherine B Peters
1 reference
Jennifer Marcello
1 reference
Leighann Bailey
1 reference
Stevie Threatt
1 reference
John H Sampson
1 reference
29 April 2011
1 reference
1 reference
Identifiers
1 reference